scPharmaceuticals Inc. Insider Trading for November 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in scPharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in scPharmaceuticals Inc. for November 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 24 2017 | SCPH | scPharmaceuticals ... | SUN PHARMACEUTICAL INDUSTRIES ... | 10% Owner | Option Exercise | C | 0.00 | 13,000,000 | 0 | 0 | |
Nov 24 2017 | SCPH | scPharmaceuticals ... | SUN PHARMACEUTICAL INDUSTRIES ... | 10% Owner | Buy | P | 14.00 | 357,143 | 5,000,002 | 357,143 | 0 to 357.1 K |
Nov 24 2017 | SCPH | scPharmaceuticals ... | SUN PHARMACEUTICAL INDUSTRIES ... | 10% Owner | Buy | C | 0.00 | 1,810,536 | 0 | 1,810,536 | 0 to 1.8 M |
Nov 21 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Option Exercise | C | 0.00 | 309,501 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Buy | C | 0.00 | 43,104 | 0 | 43,104 | 0 to 43.1 K |
Nov 21 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Buy | C | 0.00 | 34,818 | 0 | 34,818 | 0 to 34.8 K |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Coleman Dorothy | Director | Option Exercise | C | 0.00 | 103,024 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Coleman Dorothy | Director | Buy | C | 0.00 | 14,348 | 0 | 14,348 | 0 to 14.3 K |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Option Exercise | C | 0.00 | 7,067,945 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Option Exercise | C | 0.00 | 11,092,383 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Buy | P | 14.00 | 654,762 | 9,166,668 | 3,183,986 | 2.5 M to 3.2 M (+25.89 %) |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Buy | C | 0.00 | 984,366 | 0 | 2,529,224 | 1.5 M to 2.5 M (+63.72 %) |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Buy | C | 0.00 | 1,544,858 | 0 | 1,544,858 | 0 to 1.5 M |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Option Exercise | C | 0.00 | 7,067,945 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Option Exercise | C | 0.00 | 11,092,383 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Buy | C | 0.00 | 984,366 | 0 | 2,529,224 | 1.5 M to 2.5 M (+63.72 %) |
Nov 21 2017 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Buy | C | 0.00 | 1,544,858 | 0 | 1,544,858 | 0 to 1.5 M |
Nov 21 2017 | SCPH | scPharmaceuticals ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 18,500,000 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,576,532 | 0 | 2,576,532 | 0 to 2.6 M |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 302,652 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 443,708 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,263,649 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 10,649,003 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | P | 14.00 | 26,190 | 366,660 | 130,135 | 103.9 K to 130.1 K (+25.20 %) |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | C | 0.00 | 42,150 | 0 | 103,945 | 61.8 K to 103.9 K (+68.21 %) |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | C | 0.00 | 61,795 | 0 | 61,795 | 0 to 61.8 K |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | P | 14.00 | 628,572 | 8,800,008 | 3,123,302 | 2.5 M to 3.1 M (+25.20 %) |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | C | 0.00 | 1,011,623 | 0 | 2,494,730 | 1.5 M to 2.5 M (+68.21 %) |
Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | C | 0.00 | 1,483,107 | 0 | 1,483,107 | 0 to 1.5 M |
Nov 21 2017 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 18,500,000 | 0 | 0 | |
Nov 21 2017 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.00 | 833,333 | 11,666,662 | 3,409,865 | 2.6 M to 3.4 M (+32.34 %) |
Nov 21 2017 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 2,576,532 | 0 | 2,576,532 | 0 to 2.6 M |